De
Deerfield Mgmt
New York NYFounded 2005100 employees
Private CapbiotechPrivateOncology
Platform: Health Invest
Market Cap
N/A
All Drugs
4
Clinical Trials
7
Failed / Terminated
2
FDA Approved
0
Drug Pipeline (4 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Datocapivasertib | DEE-1600 | Phase 2/3 | 2 | BTK | HNSCC | ||
| Cevicilimab | DEE-8839 | Phase 3 | 1 | B7-H3 | DravetALL | ||
| Adagrazumab | DEE-889 | Phase 3 | 3 | CGRP | NMOSDSCLC | ||
| DEE-8943 | DEE-8943 | Phase 2/3 | 1 | WRN | CML |
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (8)